|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
2,630,000,000 |
Market
Cap: |
394.29(B) |
Last
Volume: |
8,458,670 |
Avg
Vol: |
8,314,942 |
52
Week Range: |
$144.45 - $174.48 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
|
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
|
S&P 100 |
|
S&P 500 |
|
MAJOR MARKET |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 21 |
Guru Rank Value : 20.3 |
Guru Occurances : 6 |
|
|
|
|
|
|
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
68,288 |
68,288 |
115,451 |
522,170 |
Total Sell Value |
$10,723,734 |
$10,723,734 |
$18,652,688 |
$88,845,171 |
Total People Sold |
2 |
2 |
5 |
10 |
Total Sell Transactions |
2 |
2 |
5 |
24 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Decker Robert J |
Controller, CAO |
|
2021-12-07 |
4 |
OE |
$72.54 |
$362,700 |
D/D |
5,000 |
19,215 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2021-06-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
912 |
150,322 |
|
- |
|
Wengel Kathryn E |
EVP, Chief GSC Officer |
|
2021-02-12 |
4 |
D |
$165.55 |
$730,738 |
D/D |
(4,414) |
64,423 |
|
- |
|
Wengel Kathryn E |
EVP, Chief GSC Officer |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,362 |
68,837 |
|
- |
|
Gorsky Alex |
Chairman, CEO |
|
2021-02-12 |
4 |
D |
$165.55 |
$5,248,928 |
D/D |
(31,706) |
476,219 |
|
- |
|
Gorsky Alex |
Chairman, CEO |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
75,105 |
507,925 |
|
- |
|
Wolk Joseph J |
Exec VP, CFO |
|
2021-02-12 |
4 |
D |
$165.55 |
$241,041 |
D/D |
(1,456) |
23,057 |
|
- |
|
Wolk Joseph J |
Exec VP, CFO |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,086 |
24,513 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2021-02-12 |
4 |
D |
$165.55 |
$1,075,082 |
D/D |
(6,494) |
151,234 |
|
- |
|
Ullmann Michael H |
Exec VP, General Counsel |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,444 |
157,728 |
|
- |
|
Mcevoy Ashley |
EVP, WW Chair, Medical Devices |
|
2021-02-12 |
4 |
D |
$165.55 |
$774,443 |
D/D |
(4,678) |
30,156 |
|
- |
|
Mcevoy Ashley |
EVP, WW Chair, Medical Devices |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,136 |
34,834 |
|
- |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2021-02-12 |
4 |
D |
$165.55 |
$942,973 |
D/D |
(5,696) |
107,343 |
|
- |
|
Fasolo Peter |
Exec VP, Chief HR Officer |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,873 |
113,039 |
|
- |
|
Taubert Jennifer L |
EVP, WW Chair, Pharmaceuticals |
|
2021-02-12 |
4 |
D |
$165.55 |
$1,004,061 |
D/D |
(6,065) |
115,126 |
|
- |
|
Taubert Jennifer L |
EVP, WW Chair, Pharmaceuticals |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,606 |
121,191 |
|
- |
|
Sneed Michael E |
EVP, Global Corp Aff & CCO |
|
2021-02-12 |
4 |
D |
$165.55 |
$515,357 |
D/D |
(3,113) |
62,177 |
|
- |
|
Sneed Michael E |
EVP, Global Corp Aff & CCO |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,211 |
65,290 |
|
- |
|
Stoffels Paulus |
Vice Chair, Exec Committee |
|
2021-02-12 |
4 |
D |
$165.55 |
$2,370,179 |
D/D |
(14,317) |
275,547 |
|
- |
|
Stoffels Paulus |
Vice Chair, Exec Committee |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
35,062 |
289,864 |
|
- |
|
Mongon Thibaut |
Exec VP, WW Chair, Consumer |
|
2021-02-12 |
4 |
D |
$165.55 |
$558,731 |
D/D |
(3,375) |
39,585 |
|
- |
|
Mongon Thibaut |
Exec VP, WW Chair, Consumer |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,145 |
42,960 |
|
- |
|
Duato Joaquin |
Vice Chair, Exec Committee |
|
2021-02-12 |
4 |
D |
$165.55 |
$2,224,661 |
D/D |
(13,438) |
196,052 |
|
- |
|
Duato Joaquin |
Vice Chair, Exec Committee |
|
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,021 |
209,490 |
|
- |
|
Decker Robert J |
Controller, CAO |
|
2021-02-12 |
4 |
D |
$165.55 |
$80,457 |
D/D |
(486) |
14,215 |
|
- |
|
104 Records found
|
|
Page 4 of 5 |
|
|